Skip to main content
Caplight Logo









DND Biotech

DND Biotech

Private
PisaHealthcare & Life Scienceshttps://www.dndbiotech.it/

Last Round

Accelerator

Jun 20, 2022

Total Funding Raised

$570,000

Company Overview

DND Biotech is a biotechnology company that develops bio-based technologies for environmental safeguarding, public health, and soil fertility restoration.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

Alzheimer's disease diagnosisAlzheimer's blood testin-vitro diagnosticsIVDearly diagnosisliquid biopsyneurodegenerative diseasesnon-invasive diagnosticsAlzheimer's biomarkersdiagnostic kitsbiotech R&D servicesprecision medicinemedical devices

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DND Biotech Comparables

Compare DND Biotech with similar companies based on industry and business-model similarity.

DND Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Diadem
89%
C2N Diagnostics
78%
ALZpath, Inc.
78%

DND Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 20, 2022

Key People

Founding team and executive leadership

Cosimo Masini

CEO

Executive Team

DND Biotech Investors

Notable investors and investment history

DND Biotech investors
InvestorRounds
Intesa Sanpaolo Innovation CenterAccelerator
Fondazione PisaSeed
CDP Venture Capital SGRAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2026

    Monthly visitors grew 182% MoM, reaching 2.2K.

  • Oct 29, 2024

    Monthly visitors increased 65% MoM, from 523 to 865.

DND Biotech Filings

Explore SEC and related filing metadata, where available.

DND Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DND Biotech's valuation, stock price, and market status.

Is DND Biotech a public or private company?

DND Biotech is a private company.

What is the current stock price of DND Biotech?

DND Biotech is a private company, so its shares have no public market price. Caplight tracks DND Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is DND Biotech worth (valuation)?

Valuation information for DND Biotech is not publicly available.

Can I buy DND Biotech stock?

DND Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was DND Biotech's last funding round?

DND Biotech's most recent funding round was Accelerator on June 20, 2022.

Who are the main investors in DND Biotech?

Key investors in DND Biotech include Fondazione Pisa.

Will DND Biotech IPO soon?

No public IPO plans have been announced for DND Biotech.

How can I track DND Biotech secondary market activity?

Caplight tracks bids, offers, and trades in DND Biotech's shares on secondary markets.

Firmographic Details

HeadquartersPisa
Employee Range9
Year FoundedN/A
Last FundingJun 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?